Skip to main content
NCBI home page
Indian Journal of Clinical Biochemistry logoLink to Indian Journal of Clinical Biochemistry
. 2008 Mar 6;23(1):41–44. doi: 10.1007/s12291-008-0010-x

Lipid peroxidation and antioxidant status in patients with rheumatoid arthritis

Krishna Mohan Surapneni 1,✉, V S Chandrasada Gopan 2
PMCID: PMC3453665  PMID: 23105718

Abstract

The changes in the erythrocyte lipid peroxidation products (MDA), levels of glutathione (GSH), ascorbic acid and plasma vitamin E (non enzymatic antioxidant parameters) and activities of antioxidant enzymes superoxide dismutase (SOD), glutathione peroxidase (GPX), catalase in erythrocytes and plasma glutathione - S - transferase (GST) activity were estimated in patients with rheumatoid arthritis. This work was undertaken to assess oxidative stress and anti oxidant status in patients with rheumatoid arthritis. It was observed that there was a significant increase in erythrocyte MDA levels, activities of SOD, GPX, plasma GST and a significant decrease in erythrocyte GSH, ascorbic acid, plasma vitamin E levels and catalse activity in patients with rheumatoid arthritis when compared to controls. The results of our study suggests higher oxygen free radical production, evidenced by increased MDA and decreased GSH, ascorbic acid, vitamin E and Catalase activity, support to the oxidative stress in rheumatoid arthritis. The increased activities of antioxidant enzymes may be a compensatory regulation in response to increased oxidative stress.

Key Words: Malondialdehyde, Glutathione, Ascorbic acid, Vitamin E, Superoxide dismutase, Catalase, Glutathione peroxidase, Glutathione -S - transferase, Rheumatoid arthritis

Full Text

The Full Text of this article is available as a PDF (42.6 KB).

References

  • 1.Deborah P.M. Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome. Clin Rheum. 2002;111:172–177. doi: 10.1053/berh.2002.0257. [DOI] [PubMed] [Google Scholar]
  • 2.Gabriel S.E. The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am. 2001;27:269–281. doi: 10.1016/S0889-857X(05)70201-5. [DOI] [PubMed] [Google Scholar]
  • 3.Shichikawa K., Inoue K., Hirota S., Maeda A., Ota H., Kilmura M., Ushiyama T., Tsujimoto M. Changes in the incidence and prevalence of rheumatoid arthritis. Ann Rheum Dis. 1999;58:751–756. doi: 10.1136/ard.58.12.751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Plaa G.L., Witschi H. Chemicals, drugs and lipid peroxidation. Ann Rev Pharmacol Toxicol. 1976;16:125–141. doi: 10.1146/annurev.pa.16.040176.001013. [DOI] [PubMed] [Google Scholar]
  • 5.Mapp P.I., Grootveld M.C. Hypoxia, oxidative stress and rheumatoid arthritis. Br Med Bull. 1995;51(2):419–436. doi: 10.1093/oxfordjournals.bmb.a072970. [DOI] [PubMed] [Google Scholar]
  • 6.Sato M., Miyazaki T. Antioxidants inhibit tumor necrosis factor-alpha mediated stimulation of interleukin-8, monocyte chemo attractant protein-1 and collagenase expression in cultured human synovial cells. J Rheumatol. 1996;23(3):432–438. [PubMed] [Google Scholar]
  • 7.Mezes M., Bartosiewicz G. Investigations on vitamin E and lipid peroxide status in rheumatic diseases. Clin Rheumatol. 1983;2(3):259–263. doi: 10.1007/BF02041400. [DOI] [PubMed] [Google Scholar]
  • 8.Ozkan Y, Yardym-Akaydyn S, Sepici A, Keskin E, Sepici V, Simsek B. Oxidative status in rheumatoid arthritis. Clin Rheumatol 2006; 25: (Epub ahead of print). [DOI] [PubMed]
  • 9.Sie H. Oxidative stress: from basic research to clinical application. Am J Med. 1991;9:31–38. doi: 10.1016/0002-9343(91)90281-2. [DOI] [PubMed] [Google Scholar]
  • 10.Cotgreave I., Moldeus P., Orrenius S. Host biochemical defense mechanisms against prooxidants. Ann Rev Pharmacol Toxicol. 1988;28:189–212. doi: 10.1146/annurev.pa.28.040188.001201. [DOI] [PubMed] [Google Scholar]
  • 11.Dodge J.F., Mitchell G., Hanahan D.J. The preparation and chemical characterization of hemoglobin free ghosts of human red blood cells. Arch Biochem Biophys. 1968;110:119–130. doi: 10.1016/0003-9861(63)90042-0. [DOI] [PubMed] [Google Scholar]
  • 12.Quist E.H. Regulation of erythrocyte membrane shape by calcium ion. Biochem Biophys Res Commun. 1980;92:631–637. doi: 10.1016/0006-291X(80)90380-0. [DOI] [PubMed] [Google Scholar]
  • 13.Beutler E., Duron O., Kelly B.M. Improved method for the determination of blood glutathione. J Lab Clin Med. 1963;61:882–888. [PubMed] [Google Scholar]
  • 14.Tietz N. W. In: Text book of clinical chemistry. Tietz N. W., editor. Philadelphia, London, Toronto: W B Saunders company; 1986. pp. 960–962. [Google Scholar]
  • 15.Baker H, Frank D, Winley N C. Clinical Vitaminology. 1968; p. 772.
  • 16.Jain S.K., Mcvie R., Duett J., Herbst J.J. Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes. 1989;38:1539–1542. doi: 10.2337/diabetes.38.12.1539. [DOI] [PubMed] [Google Scholar]
  • 17.Misra H.P., Fridovich I. The role of super oxide anion in the auto oxidation of epinephrine and a simple assay for super oxide dismutase. J Biol Chem. 1972;247:3170–3175. [PubMed] [Google Scholar]
  • 18.Beers R.F., Sizer I.W. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by Catalase. J Biol Chem. 1952;195:133–140. [PubMed] [Google Scholar]
  • 19.Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70:158–159. [PubMed] [Google Scholar]
  • 20.Warholm M, Guthenberg C, Christer von Bahr, Mannervik B. Glutathione transferases from human liver. In: Methods of enzymology, Alton Melster (Ed.). Academic Press 1985; 113: 500–501. [DOI] [PubMed]
  • 21.Kajanachumpol S., Vanichapuntu M., Verasertniyom O., Totemchokchyakarn K., Vatanasuk M. Levels of plasma lipid peroxide products and antioxidant status in rheumatoid arthritis. Southeast Asian J Trop Med Public Health. 2000;31(2):335–338. [PubMed] [Google Scholar]
  • 22.Jaswal S., Mehta H.C., Sood A.K., Kaur J. Antioxidant status in rheumatoid arthritis and role of antioxidant therapy. Clin Chim Acta. 2003;338(1–2):123–129. doi: 10.1016/j.cccn.2003.08.011. [DOI] [PubMed] [Google Scholar]
  • 23.Kartas F., Ozates I., Canatan H., Halifeoglu I., Karatepe M., Colakt R. Antioxidant status and lipid peroxidation in patients with rheumatoid arthritis. Ind J Med Res. 2003;118:178–181. [PubMed] [Google Scholar]
  • 24.Cimen M.Y., Cimen O.B., Kacmaz M., Ozturk H.S., Yorgancioglu R., Durak I. Oxidant/antioxidant status of the erythrocytes from patients with rheumatoid arthritis. Clin Rheumatol. 2000;19(4):275–277. doi: 10.1007/PL00011172. [DOI] [PubMed] [Google Scholar]
  • 25.Chandra R., Aneja R., Rewal C., Konduri R., Dass K., Agarwal S. An opium alkaloid-papaverine ameliorates ethanol induced hepatotoxicity: diminution of oxidative stress. Ind J Clin Biochem. 2000;15(2):155–160. doi: 10.1007/BF02883745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Smith G.J., Ohl V.S., Litwack G., Ligandin The Glutathione-S-Transferases, and chemically induced hepato carcinogenesis. A review, Cancer Res. 1977;37:8–14. [PubMed] [Google Scholar]
  • 27.Ostalowska A., Birkner E., Wiecha M., Kasperczyk S., Kasperczyk A., Kapolka D., Zon-Giebel A. Lipid peroxidation and antioxidant enzymes in synovial fluid of patients with primary and secondary Rheumatoid Arthritis of the knee joint. Rheumatoid Arthritis Cartilage. 2006;14(2):139–145. doi: 10.1016/j.joca.2005.08.009. [DOI] [PubMed] [Google Scholar]
  • 28.Lenzi A., Cualosso F., Gandini L., Lombardo F., Dondero F. Placebo controlled double-blind cross over trial glutathione therapy, in male infertility. Hum Reprod. 1993;9:2044. doi: 10.1093/oxfordjournals.humrep.a137909. [DOI] [PubMed] [Google Scholar]
  • 29.Kerimova A.A., Atalay M., Yusifov E.Y., Kuprin S.P., Kerimov T.M. Antioxidant enzymes;possible mechanism of gold compound treatment in rheumatoid arthritis. Pathophysiology. 2000;7(3):209–213. doi: 10.1016/S0928-4680(00)00050-X. [DOI] [PubMed] [Google Scholar]

Articles from Indian Journal of Clinical Biochemistry are provided here courtesy of Springer

RESOURCES